Literature DB >> 20088828

Thyroid hormones regulate phosphate homoeostasis through transcriptional control of the renal type IIa sodium-dependent phosphate co-transporter (Npt2a) gene.

Mariko Ishiguro1, Hironori Yamamoto, Masashi Masuda, Mina Kozai, Yuichiro Takei, Sarasa Tanaka, Tadatoshi Sato, Hiroko Segawa, Yutaka Taketani, Hidekazu Arai, Ken-Ichi Miyamoto, Eiji Takeda.   

Abstract

The type IIa renal sodium-dependent phosphate (Na/Pi) co-transporter Npt2a is implicated in the control of serum phosphate levels. It has been demonstrated previously that renal Npt2a protein and its mRNA expression are both up-regulated by the thyroid hormone T3 (3,3',5-tri-iodothyronine) in rats. However, it has never been established whether the induction was mediated by a direct effect of thyroid hormones on the Npt2a promoter. To address the role of Npt2a in T3-dependent regulation of phosphate homoeostasis and to identify the molecular mechanisms by which thyroid hormones modulate Npt2a gene expression, mice were rendered pharmacologically hypo- and hyper-thyroid. Hypothyroid mice showed low levels of serum phosphate and a marked decrease in renal Npt2a protein abundance. Importantly, we also showed that Npt2a-deficient mice had impaired serum phosphate responsiveness to T3 compared with wild-type mice. Promoter analysis with a luciferase assay revealed that the transcriptional activity of a reporter gene containing the Npt2a promoter and intron 1 was dependent upon TRs (thyroid hormone receptors) and specifically increased by T3 in renal cells. Deletion analysis and EMSAs (electrophoretic mobility-shift assays) determined that there were unique TREs (thyroid-hormone-responsive elements) within intron 1 of the Npt2a gene. These results suggest that Npt2a plays a critical role as a T3-target gene, to control phosphate homoeostasis, and that T3 transcriptionally activates the Npt2a gene via TRs in a renal cell-specific manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088828     DOI: 10.1042/BJ20090671

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

Review 1.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

Review 2.  Control of phosphate balance by the kidney and intestine.

Authors:  Ichiro Kaneko; Sawako Tatsumi; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2016-11-30       Impact factor: 2.801

Review 3.  Renal control of calcium, phosphate, and magnesium homeostasis.

Authors:  Judith Blaine; Michel Chonchol; Moshe Levi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 8.237

4.  Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood.

Authors:  Margaret Seton; Harald Jüppner
Journal:  Bone       Date:  2012-11-19       Impact factor: 4.398

5.  Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.

Authors:  C-H Lin; C-K Chang; C-W Shih; H-Y Li; K-Y Chen; W-S Yang; K-S Tsai; C-Y Wang; S-R Shih
Journal:  Osteoporos Int       Date:  2019-08-05       Impact factor: 4.507

6.  Dyslipidemia and serum mineral profiles in patients with thyroid disorders.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

Review 7.  Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Authors:  Ahmed M Shaman; Stefan R Kowalski
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.